| Literature DB >> 28598411 |
Jie Li1, Korkit Korvorapun1, Suman De Sarkar1, Torben Rogge1, David J Burns1, Svenja Warratz1, Lutz Ackermann1.
Abstract
The full control of positional selectivity is of prime importance in C-H activation technology. Chelation assistance served as the stimulus for the development of a plethora of ortho-selective arene functionalizations. In sharp contrast, meta-selective C-H functionalizations continue to be scarce, with all ruthenium-catalysed transformations currently requiring difficult to remove or modify nitrogen-containing heterocycles. Herein, we describe a unifying concept to access a wealth of meta-decorated arenes by a unique arene ligand effect in proximity-induced ruthenium(II) C-H activation catalysis. The transformative nature of our strategy is mirrored by providing a step-economical entry to a range of meta-substituted arenes, including ketones, acids, amines and phenols-key structural motifs in crop protection, material sciences, medicinal chemistry and pharmaceutical industries.Entities:
Year: 2017 PMID: 28598411 PMCID: PMC5472771 DOI: 10.1038/ncomms15430
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Figure 1Transformative ruthenium(II)-catalysed meta-C–H functionalization regime.
(a) Previous reports: selectivity control by (1) steric interactions, (2) template auxiliaries, (3) hydrogen bonding, (4) transient mediator and (5) difficult to remove or modify pyridines. (b) Unifying concept to a wealth of meta-decorated arenes.
Reaction development for meta-selective C–H functionalization.
| 1 | MesCO2H | 1,4-dioxane | 30 |
| 2 | 1-AdCO2H ( | 1,4-dioxane | 52 |
| 3 | 1-AdCO2H ( | PhH | 54 |
| 4 | 1-AdCO2H( | PhMe | 58 |
| 6 | Piv-Val-OH | PhMe | 17 |
| 7 | Boc-Val-OH | PhMe | 26 |
| 8 | Boc-Ile-OH | PhMe | 28 |
| 9 | Piv-Ile-OH ( | PhMe | 33 |
| 10 | Piv-Ile-OH ( | PhCF3 | 41 |
*[RuCl2(p-cymene)]2 (2.5 mol %), 1-AdCO2H (15 mol %). TMP = 3,4,5-trimethoxyphenyl. Reaction conditions: 1a (0.5 mmol), 2a (1.5 mmol), [RuCl2(p-cymene)]2 (5.0 mol %), ligand (30 mol %), K2CO3 (1.0 mmol), solvent (2.0 ml), 120 °C, 20 h, yield of isolated products. Bold entries indicate optimal ligands (4 and 5), solvent (PhCMe3) and corresponding yields.
Figure 2Substrate scope.
Versatility of the ruthenium(II)-catalysed meta-alkylation.
Figure 3Intramolecular competition experiment.
Alkylation occurs on the more electron-deficient aromatic group.
Figure 4Mechanistic studies.
Probing a radical-based mechanism by (a) the addition of radical scavengers (b) the use of enantiomerically enriched alkyl halide 2m and (c) the use of diasteromerically pure 2p.
Figure 5Kinetic analysis.
Order in (1) catalyst 6 and (2) reagent 1a, for detailed information, see the Supplementary Information. (3) Arrhenius plot analysis. (4) Comparison of performance with single-component ruthenium(II) arene catalysts 6 and 7.
Figure 6Late-stage diversification.
The meta-C–H functionalization of ketimines 1 as transformative platform into synthetically meaningful and biologically significant compounds. For detailed information, see the Supplementary Information. (a) One-pot remote-C–H functionalization/reduction. [a]dr=1.0:1.2. (b) One-pot meta-C–H alkylation and ortho-C–H arylation/alkylation regime. (c) Late-stage diversification to access acids 11, indoles 12, phenols 13 and anilines 14. Ar=4-MeOC6H4.